000			05554cam a2200385 i 4500
999			_c122103 _d122103 _x1
001			122103
003			ES-MaUEC
005			20230228040226.0
006			a|||| o|||| 00| 0
007			cr nn nnnanaaa
008			060602s2007 paua o |||| 0|eng d
020			_a0781793947
020			_a9780781793940
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dC#P _dYDX _dBTCTA _dYDXCP _dVAM _dLVB _dNLGGC _dDLC _dES-MaUEC _bspa
050		4	_aRC924.5.L85 _b2007 EB
245	0	0	_aDubois' lupus erythematosus _ceditors, Daniel J. Wallace, Bevra Hannahs Hahn
246	3	0	_aLupus erythematosus
250			_aSeventh edition
264		1	_aPhiladelphia _bLippincott Williams & Wilkin _c2007
300			_a1 recurso en línea (XVII, 1414 páginas) _bilustraciones
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
504			_aIncluye referencias bibliográficas e índice
505	0		_aHistorical background of discoid and systemic lupus erythematosus -- The definition and classification of systemic lupus erythematosus -- Environmental aspects of lupus -- The epidemiology of systemic lupus erythematosus -- Overview of pathogenesis of systemic lupus erythematosus -- The genetics of human lupus -- The genetics of murine systemic lupus erythematosus -- Apoptosis -- The interaction of T cells with cells of the innate immune system and B cells in the pathogenesis of SLE -- Cytokines and interferons in lupus -- B cells in systemic lupus erythematosus -- Abnormalities in immune complex clearance and Fcy receptor function -- Complement and systemic lupus erythematosus -- Mechanisms of acute inflammation and vascular injury in systemic lupus erythematosus -- Idiotypes and idiotype networks -- The importance of sex hormones in systemic lupus erythematosus -- Neuroendocrine immune interactions: principles and relevance to systemic lupus erythematosus -- Animal models of systemic lupus erythematosus -- Pathogenesis of atherosclerosis in lupus -- Autoantigens and defects in immune tolerance in lupus -- The structure and derivation of antibodies and autoantibodies -- Antinuclear antibodies: an overview -- Antibodies to DNA -- Antibodies to histones and nucleosome-related antigens -- Antibodies to Ro/SSA and La/SSB -- Antibodies to spliceosomal components -- The lupus anticoagulant and antiphospholipid antibodies -- Other serologic abnormalities in systemic lupus erythematosus -- Pathomechanisms of cutaneous lupus erythematosus -- Lupus-specific skin disease (cutaneous LE) -- Lupus-nonspecific skin disease -- The clinical presentation of systemic lupus erythematosus -- The musculoskeletal system -- Cardiovascular manifestations of lupus -- Pulmonary manifestations of systemic lupus erythematosus --
505	0		_aClinical apsects of vasculitis and selected cutaneovascular manifestations of systemic lupus erythematosus -- The nervous system -- Psychopathology of lupus and neuroimaging -- Sjogren's syndrome -- Ocular, aural, and oral manifestations -- Hematologic and lymphoid abnormalities in systemic lupus erythematosus -- Gastrointestinal and hepatic manifestations -- Systemic lupus erythematosus in childhood and adolescence -- Drug-induced lupus -- Infections in systemic lupus erythematosus -- Serum and plasma protein abnormalities and other clinical laboratory determinations in systemic lupus erythematosus -- Clinical indices in the assessment of lupus -- Clinical application of serologic abnormalities in systemic lupus erythematosus -- Differential diagnosis and disease associations -- Mixed connective-tissue disease and overlap syndromes -- The mother in systemic lupus erythematosus -- The fetus in systemic lupus erythematosus -- Neonatal lupus -- Reproductive issues in women with autoimmune disease -- Lupus nephritis: pathology and pathogenesis -- Clinical and laboratory features of lupus nephritis -- Principles of therapy and local measures -- Nonsteroidals and salicylates for systemic lupus erythematosus -- Antimalarial therapies -- Systemic glucocorticoid therapy in systemic lupus erythematosus -- Immunosuppressive drug therapy -- Nonpharmacologic and complementary therapeutic modalities -- Fibromyalgia in SLE and the use of complementary and alternative medicine -- Hormones and gender-related issues -- Clinical and management aspects of the antiphospholipid antibody syndrome -- Additional therapies used in the management of lupus -- Adjunctive measures and issues: allergies, antibiotics, vaccines and disability -- Issues in drug development in SLE: clinical trial design, outcome, measures, and biomarkers -- Prognosis, mortality, and morbidity in systemic lupus erythematosus -- Biologics and stem cell therapies for lupus -- Appendics: A patient's guide to lupus erythematosus -- Lupus resource materials -- The medical outcome survey short-form general health survey.
988			_aLWW Classic Book Collection_2020
650		7	_aLupus eritematoso sistémico _2embne _9667662
700	1		_aWallace, Daniel J. _q(Daniel Jeffrey), _d1949- _eeditor literario
700	1		_aHahn, Bevra _eeditor literario
700	1		_aDubois, Edmund L. _eautor anterior
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https%3A%2F%2Fovidsp.ovid.com%2Fovidweb.cgi%3FT%3DJS%26NEWS%3Dn%26CSC%3DY%26PAGE%3Dbooktext%26D%3Dbooks%26AN%3D01257006%24%26XPATH%3D%2FPG%280%29%26EPUB%3DY _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b08/2020 _dz _eh _zSI